{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:10:08Z","timestamp":1759493408853,"version":"build-2065373602"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Association for Science and Technology's \"Golden-Bridge Seed Funding Program\"","award":["ZZ22006"],"award-info":[{"award-number":["ZZ22006"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-011"],"award-info":[{"award-number":["2022-PUMCH-B-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14807-4","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:32:48Z","timestamp":1759491168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression and prognostic value of MCM2 in type B thymomas"],"prefix":"10.1186","volume":"25","author":[{"given":"Xin","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xintao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingfang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"10 Suppl 4","key":"14807_CR1","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","volume":"5","author":"EA Engels","year":"2010","unstructured":"Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010;5(10 Suppl 4):S260\u2013265.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"14807_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, et al. The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors? J Thorac Oncol. 2022;17(2):200\u201313.","journal-title":"J Thorac Oncol"},{"issue":"7","key":"14807_CR3","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","volume":"17","author":"CR Thomas","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the Art. J Clin Oncol. 1999;17(7):2280\u20139.","journal-title":"J Clin Oncol"},{"issue":"7 Suppl 3","key":"14807_CR4","doi-asserted-by":"publisher","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","volume":"6","author":"F Detterbeck","year":"2011","unstructured":"Detterbeck F, Youssef S, Ruffini E, Okumura M. A review of prognostic factors in thymic malignancies. J Thorac Oncol. 2011;6(7 Suppl 3):S1698\u20131704.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"14807_CR5","doi-asserted-by":"publisher","first-page":"13408","DOI":"10.1002\/cam4.6043","volume":"12","author":"X Du","year":"2023","unstructured":"Du X, Cui J, Yu XT, Yu L. Risk factor analysis of thymoma resection and its value in guiding clinical treatment. Cancer Med. 2023;12(12):13408\u201314.","journal-title":"Cancer Med"},{"issue":"2","key":"14807_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","volume":"33","author":"M Radovich","year":"2018","unstructured":"Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, et al. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell. 2018;33(2):244\u201358. e210.","journal-title":"Cancer Cell"},{"issue":"7","key":"14807_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844\u20137.","journal-title":"Nat Med"},{"key":"14807_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1146\/annurev.biochem.71.110601.135425","volume":"71","author":"SP Bell","year":"2002","unstructured":"Bell SP, Dutta A. DNA replication in eukaryotic cells. Annu Rev Biochem. 2002;71:333\u201374.","journal-title":"Annu Rev Biochem"},{"issue":"25","key":"14807_CR9","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1038\/onc.2010.125","volume":"29","author":"D Kunnev","year":"2010","unstructured":"Kunnev D, Rusiniak ME, Kudla A, Freeland A, Cady GK, Pruitt SC. DNA damage response and tumorigenesis in Mcm2-deficient mice. Oncogene. 2010;29(25):3630\u20138.","journal-title":"Oncogene"},{"issue":"12","key":"14807_CR10","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1634\/stemcells.2007-0483","volume":"25","author":"SC Pruitt","year":"2007","unstructured":"Pruitt SC, Bailey KJ, Freeland A. Reduced Mcm2 expression results in severe stem\/progenitor cell deficiency and cancer. Stem Cells. 2007;25(12):3121\u201332.","journal-title":"Stem Cells"},{"issue":"Suppl 2","key":"14807_CR11","first-page":"S228","volume":"6","author":"E Ruffini","year":"2014","unstructured":"Ruffini E, Venuta F. Management of thymic tumors: a European perspective. J Thorac Dis. 2014;6(Suppl 2):S228\u2013237.","journal-title":"J Thorac Dis"},{"issue":"22","key":"14807_CR12","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","volume":"15","author":"N Girard","year":"2009","unstructured":"Girard N, Shen R, Guo T, Zakowski MF, Heguy A, Riely GJ, et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res. 2009;15(22):6790\u20139.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"14807_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/cncr.20811","volume":"103","author":"DN Ionescu","year":"2005","unstructured":"Ionescu DN, Sasatomi E, Cieply K, Nola M, Dacic S. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer. 2005;103(3):630\u20136.","journal-title":"Cancer"},{"issue":"20","key":"14807_CR14","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1002\/cncr.25367","volume":"116","author":"PA Zucali","year":"2010","unstructured":"Zucali PA, Petrini I, Lorenzi E, Merino M, Cao L, Di Tommaso L, et al. Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas. Cancer. 2010;116(20):4686\u201395.","journal-title":"Cancer"},{"issue":"9","key":"14807_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","volume":"5","author":"N Girard","year":"2010","unstructured":"Girard N, Teruya-Feldstein J, Payabyab EC, Riely GJ, Rusch VW, Kris MG, et al. Insulin-like growth factor-1 receptor expression in thymic malignancies. J Thorac Oncol. 2010;5(9):1439\u201346.","journal-title":"J Thorac Oncol"},{"issue":"3","key":"14807_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1067\/mtc.2002.124389","volume":"124","author":"M Tomita","year":"2002","unstructured":"Tomita M, Matsuzaki Y, Edagawa M, Maeda M, Shimizu T, Hara M, et al. Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors. J Thorac Cardiovasc Surg. 2002;124(3):493\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"14807_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","volume":"43","author":"CC Pan","year":"2003","unstructured":"Pan CC, Chen PC, Wang LS, Lee JY, Chiang H. Expression of apoptosis-related markers and HER-2\/neu in thymic epithelial tumours. Histopathology. 2003;43(2):165\u201372.","journal-title":"Histopathology"},{"issue":"10","key":"14807_CR18","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/cncr.21433","volume":"104","author":"TC Mineo","year":"2005","unstructured":"Mineo TC, Ambrogi V, Mineo D, Baldi A. Long-term disease-free survival of patients with radically resected thymomas: relevance of cell-cycle protein expression. Cancer. 2005;104(10):2063\u201371.","journal-title":"Cancer"},{"issue":"1","key":"14807_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1378\/chest.08-2482","volume":"136","author":"T Khoury","year":"2009","unstructured":"Khoury T, Arshad A, Bogner P, Ramnath N, Zhang S, Chandrasekhar R, Wilding G, Alrawi S, Tan D. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms. Chest. 2009;136(1):220\u20138.","journal-title":"Chest"},{"issue":"23","key":"14807_CR20","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1200\/JCO.2003.04.121","volume":"21","author":"MA Gonzalez","year":"2003","unstructured":"Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, et al. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol. 2003;21(23):4306\u201313.","journal-title":"J Clin Oncol"},{"issue":"10","key":"14807_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neo.2019.07.011","volume":"21","author":"MSM Issac","year":"2019","unstructured":"Issac MSM, Yousef E, Tahir MR, Gaboury LA. MCM2, MCM4, and MCM6 in breast cancer: clinical utility in diagnosis and prognosis. Neoplasia. 2019;21(10):1015\u201335.","journal-title":"Neoplasia"},{"issue":"22","key":"14807_CR22","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1200\/JCO.2001.19.22.4259","volume":"19","author":"N Ramnath","year":"2001","unstructured":"Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, et al. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J Clin Oncol. 2001;19(22):4259\u201366.","journal-title":"J Clin Oncol"},{"issue":"9","key":"14807_CR23","first-page":"2712","volume":"7","author":"MV Meng","year":"2001","unstructured":"Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res. 2001;7(9):2712\u20138.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"14807_CR24","first-page":"1075","volume":"8","author":"K Rodins","year":"2002","unstructured":"Rodins K, Cheale M, Coleman N, Fox SB. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin Cancer Res. 2002;8(4):1075\u201381.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"14807_CR25","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1158\/1078-0432.CCR-04-1776","volume":"11","author":"TJ Dudderidge","year":"2005","unstructured":"Dudderidge TJ, Stoeber K, Loddo M, Atkinson G, Fanshawe T, Griffiths DF, et al. Mcm2, geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma. Clin Cancer Res. 2005;11(7):2510\u20137.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"14807_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0302-2838(02)00580-8","volume":"43","author":"S Kruger","year":"2003","unstructured":"Kruger S, Thorns C, Stocker W, Muller-Kunert E, Bohle A, Feller AC. Prognostic value of MCM2 immunoreactivity in stage T1 transitional cell carcinoma of the bladder. Eur Urol. 2003;43(2):138\u201345.","journal-title":"Eur Urol"},{"issue":"7","key":"14807_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/sj.bjc.6604967","volume":"100","author":"A Torres-Rendon","year":"2009","unstructured":"Torres-Rendon A, Roy S, Craig GT, Speight PM. Expression of Mcm2, Geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. Br J Cancer. 2009;100(7):1128\u201334.","journal-title":"Br J Cancer"},{"issue":"1","key":"14807_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s10020-022-00555-9","volume":"28","author":"Y Sun","year":"2022","unstructured":"Sun Y, Cheng Z, Liu S. MCM2 in human cancer: functions, mechanisms, and clinical significance. Mol Med. 2022;28(1):128.","journal-title":"Mol Med"},{"key":"14807_CR29","doi-asserted-by":"crossref","unstructured":"Yin M, Baslan T, Walker RL, Zhu YJ, Freeland A, Matsukawa T, Sridharan S, Nussenzweig A, Pruitt SC, Lowe SW et al. A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia. JCI Insight. 2019;4(23):e131434.","DOI":"10.1172\/jci.insight.131434"},{"issue":"7833","key":"14807_CR30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41586-020-2842-3","volume":"587","author":"H Sedlackova","year":"2020","unstructured":"Sedlackova H, Rask MB, Gupta R, Choudhary C, Somyajit K, Lukas J. Equilibrium between nascent and parental MCM proteins protects replicating genomes. Nature. 2020;587(7833):297\u2013302.","journal-title":"Nature"},{"issue":"10","key":"14807_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nrc2500","volume":"8","author":"JJ Blow","year":"2008","unstructured":"Blow JJ, Gillespie PJ. Replication licensing and cancer\u2013a fatal entanglement? Nat Rev Cancer. 2008;8(10):799\u2013806.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"14807_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1042\/BST20221465","volume":"51","author":"Y Hatoyama","year":"2023","unstructured":"Hatoyama Y, Kanemaki MT. The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. Biochem Soc Trans. 2023;51(3):1289\u201395.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"14807_CR33","doi-asserted-by":"publisher","first-page":"e1001110","DOI":"10.1371\/journal.pgen.1001110","volume":"6","author":"CH Chuang","year":"2010","unstructured":"Chuang CH, Wallace MD, Abratte C, Southard T, Schimenti JC. Incremental genetic perturbations to MCM2-7 expression and subcellular distribution reveal exquisite sensitivity of mice to DNA replication stress. PLoS Genet. 2010;6(9):e1001110.","journal-title":"PLoS Genet"},{"issue":"36","key":"14807_CR34","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1038\/onc.2011.566","volume":"31","author":"ME Rusiniak","year":"2012","unstructured":"Rusiniak ME, Kunnev D, Freeland A, Cady GK, Pruitt SC. Mcm2 deficiency results in short deletions allowing high resolution identification of genes contributing to lymphoblastic lymphoma. Oncogene. 2012;31(36):4034\u201344.","journal-title":"Oncogene"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14807-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14807-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:32:51Z","timestamp":1759491171000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14807-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14807"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14807-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Beijing Tongren Hospital (Approval Number: TRECKY2021-175). Informed consent was waived due to the retrospective nature of the study. The research was conducted in compliance with the principles of the Declaration of Helsinki ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1506"}}